ArticleJACC. Case reports2026
Transcatheter ASD Closure in a Bidirectional Cardiopulmonary Diagnostic Blind Spot: When Dyspnea Does Not Fit.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDyspnea in adults with secundum atrial septal defect (ASD) is often attributed to shunt physiology, whereas coexisting airway disease may remain unrecognized. Conversely, clinically significant ASD may be overlooked in patients presenting with predominant respiratory symptoms, creating a bidirectional cardiopulmonary diagnostic blind spot. CASE SUMMARY: We retrospectively identified 8 adults (median age 55.5 years; 5 women) with secundum ASD (15-30 mm) and clinically significant airway disease through bidirectional cardiology-pulmonology referral (6 cardiology-to-pulmonology; 2 pulmonology-to-cardiology). Airway physiology was obstructive in 6, restrictive in 1, and mixed in 1, with bronchodilator reversibility in 5. Integrated cardiopulmonary evaluation and respiratory optimization improved symptom attribution and guided individualized management. Seven patients underwent transcatheter ASD closure (median device size, 38 mm), including fenestrated closure in 2 after balloon occlusion testing identified impaired left ventricular compliance; 1 deferred closure after symptomatic improvement with respiratory therapy alone. No procedural complications occurred, and 1 noncardiac death occurred 5 years after intervention. TAKE-HOME MESSAGES: Dyspnea in adults with ASD may reflect combined cardiac and airway disease. Disproportionate symptoms should prompt integrated cardiopulmonary evaluation. Accurate symptom attribution underpins respiratory optimization and individualized ASD closure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.